Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2025-12-26 @ 2:57 AM
NCT ID: NCT01270802
Description: Laboratory toxicities were assessed at week 8 and week 24.
Frequency Threshold: 5
Time Frame: 6 months
Study: NCT01270802
Study Brief: Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Continued Tenofovir/Emtricitabine/Efavirenz Tenofovir/emtricitabine/efavirenz : Continued therapy with tenofovir/emtricitabine/efavirenz None None 0 15 3 15 View
Switch to Tenofovir/Emtricitabine/Raltegravir Tenofovir/emtricitabine/efavirenz is switched to tenofovir/emtricitabine/raltegravir Tenofovir/emtricitabine/raltegravir : Efavirenz will be switched to raltegravir 400mg orally twice daily while continuing tenofovir/emtricitabine None None 0 15 1 15 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Virologic failure SYSTEMATIC_ASSESSMENT Infections and infestations None View
Neutropenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Impaired fasting glucose SYSTEMATIC_ASSESSMENT Endocrine disorders None View
Diastolic hypertension SYSTEMATIC_ASSESSMENT Vascular disorders None View